However, genistein did significantly reduce microvessel density, as reflected by decreased CD34 staining in tumor tissues, and it did so in a dose-dependent manner, with the strongest reduction observed in the 75 mg/kg/d group (p=<0.000) (Fig. 4, lower panel). The gene discussed is CD34; the disease is neoplasm.